Vestal Point Capital’s Pulmonx LUNG Stock Holding History

Vestal Point Capital’s Portfolio LUNG Stock Details LUNG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-830,000	Closed	-$1.34M	–	98
2025 Q3	$1.34M	Buy	+830,000	New	+$1.74M	0.06%	78

Other funds holding LUNG

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

ECM

ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vestal Point Capital's LUNG Position: Q4 2025 in Review

Vestal Point Capital sold out of Pulmonx (LUNG) in Q4 2025, closing a stake of 830,000 shares — an estimated $1.34M sold.

Vestal Point Capital first reported a position in LUNG in Q3 2025 and held it in 1 quarter. The position peaked at $1.34M in Q3 2025. 112 funds tracked by Wall St. Rank hold LUNG as of Q4 2025.

Vestal Point Capital reported no remaining Pulmonx position as of Q4 2025 after selling out during the quarter.
Vestal Point Capital sold 830,000 Pulmonx shares in Q4 2025, an estimated $1.34M.
Vestal Point Capital first reported a position in Pulmonx in Q3 2025 and held it in 1 quarter.
Vestal Point Capital's Pulmonx position peaked at $1.34M in Q3 2025.
112 funds tracked by Wall St. Rank held Pulmonx as of Q4 2025.

Based on Vestal Point Capital's 13F filing for Q4 2025, filed 17 Feb 2026.